申请人:Jernstedt Henrik
公开号:US20090326018A1
公开(公告)日:2009-12-31
The invention provides a compound of formula (I) or a pharmaceutically acceptable ester, amide, solvate or salt thereof, including a salt of such an ester or amide, and a solvate of such an ester, amide or salt. The invention also provides also provides the use of such compounds in the treatment or prophylaxis of a condition associated with a disease or disorder associated with estrogen receptor activity. Formula (I), wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
, R
9
, R
10
, R
11
and R
12
are as defined in the specification, and wherein either the bond between the C1 and C2 carbon atoms is a double bond or the bond between the C2 and C3 carbon atoms is a double bond, R
2
being absent when the bond between the C1 and C2 carbon atoms is a double bond.
本发明提供了化合物(I)或其药学上可接受的酯、酰胺、溶剂合物或盐,包括这种酯或酰胺的盐,以及这种酯、酰胺或盐的溶剂合物。本发明还提供了在与雌激素受体活性相关的疾病或紊乱的情况下使用这些化合物进行治疗或预防的方法。其中,化合物(I)的R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11和R12如规范中所定义,在C1和C2碳原子之间的键是双键或C2和C3碳原子之间的键是双键时,R2不存在。